The Efficacy and Risk Profile of c-Met inhibitors in Non-small Cell Lung Cancer: a Meta-analysis
Crossref DOI link: https://doi.org/10.1038/srep35770
Published Online: 2016-10-27
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ye, Sa
Li, Jiuke
Hao, Ke
Yan, Jianping
Zhou, Hongbin
Text and Data Mining valid from 2016-10-27
Version of Record valid from 2016-10-27
Article History
Received: 28 May 2016
Accepted: 3 October 2016
First Online: 27 October 2016
Competing interests
: The authors declare no competing financial interests.